Viridian Therapeutics, Inc. (VRDN)
19.03
-0.53
(-2.71%)
USD |
NASDAQ |
Oct 16, 16:00
18.76
-0.27
(-1.42%)
After-Hours: 20:00
Viridian Therapeutics Cash and Short Term Investments (Quarterly) : 981.53M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 981.53M |
| March 31, 2026 | 762.18M |
| December 31, 2025 | 874.65M |
| September 30, 2025 | 490.90M |
| June 30, 2025 | 563.36M |
| March 31, 2025 | 636.63M |
| December 31, 2024 | 717.58M |
| September 30, 2024 | 753.24M |
| June 30, 2024 | 571.37M |
| March 31, 2024 | 613.19M |
| December 31, 2023 | 477.37M |
| September 30, 2023 | 313.01M |
| June 30, 2023 | 334.29M |
| March 31, 2023 | 373.86M |
| December 31, 2022 | 424.55M |
| September 30, 2022 | 431.32M |
| June 30, 2022 | 161.21M |
| March 31, 2022 | 175.43M |
| December 31, 2021 | 196.96M |
| September 30, 2021 | 213.81M |
| June 30, 2021 | 109.30M |
| March 31, 2021 | 117.10M |
| December 31, 2020 | 127.64M |
| September 30, 2020 | 30.08M |
| June 30, 2020 | 30.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 36.10M |
| December 31, 2019 | 26.84M |
| September 30, 2019 | 33.84M |
| June 30, 2019 | 43.95M |
| March 31, 2019 | 51.04M |
| December 31, 2018 | 62.48M |
| September 30, 2018 | 70.53M |
| June 30, 2018 | 76.26M |
| March 31, 2018 | 78.10M |
| December 31, 2017 | 47.44M |
| September 30, 2017 | 42.80M |
| June 30, 2017 | 46.34M |
| March 31, 2017 | 54.27M |
| December 31, 2016 | 22.10M |
| September 30, 2016 | 5.351M |
| June 30, 2016 | 6.501M |
| March 31, 2016 | 8.56M |
| December 31, 2015 | 10.83M |
| September 30, 2015 | 12.12M |
| June 30, 2015 | 10.45M |
| March 31, 2015 | 13.27M |
| December 31, 2014 | 5.169M |
| September 30, 2014 | 6.439M |
| June 30, 2014 | 7.746M |
| March 31, 2014 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.863B |
| TG Therapeutics, Inc. | 552.25M |
| Travere Therapeutics, Inc. | 489.18M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |